Back to Directory
pharmaceuticals logo

Sobi - Swedish Orphan Biovitrum AB (publ) | Company Profile

12/11/2025

Contact Information

👤
Sobi - Swedish Orphan Biovitrum AB (publ)
🏢
Sobi - Swedish Orphan Biovitrum AB (publ)
📍
Norra Stationsgatan 93A, Stockholm, Stockholm County 11364, SE

Industry & Market

Primary Industry
pharmaceuticals
Location
Stockholm, Stockholm County, Sweden
Public Trading
NASDAQ: SOBI

Company Metrics

👥Total Employees
388
⚙️Engineering
24
💼Sales Team
25
📈Marketing
21
📅Founded
2009
💰Revenue
2.6B

Funding Information

Annual Revenue
$2,559,226,000
Publicly traded company

Headcount Distribution

Total Employees
388
Departments
19

By Department

Department Breakdown

Business Development
Operations
Finance
Human Resources
Sales
Engineering
Others

Technology Stack

Analytics & Tracking

Google Tag Manager

Development

Bootstrap Framework

Video & Media

Vimeo

Email & Communication

Outlook
Total: 23 technologies

Keywords & Focus Areas

orphan drugshereditary metabolic disordershaemophiliabiopharmaceuticalspatient accessrare diseaseshaematologyhematologyimmunologyautoimmunepharmaceutical manufacturingpharmaceuticalsmedical
13 total keywords

Sobi - Swedish Orphan Biovitrum AB (publ)

Overview

Swedish Orphan Biovitrum AB (Sobi) is a biopharmaceutical company based in Stockholm, Sweden. It focuses on developing, manufacturing, and marketing treatments for rare diseases, particularly in hematology, immunology, and specialty care. Sobi specializes in innovative therapies for conditions such as hemophilia, inflammation, genetic and metabolic diseases, and amyotrophic lateral sclerosis (ALS).

The company offers a range of biologics and protein-based therapies, with a strong emphasis on orphan drugs for rare diseases. Sobi has developed treatments like recombinant clotting factors for hemophilia A and B, as well as enzyme replacement therapies. It also collaborates with partner companies to manufacture specialty products and has established strategic partnerships with organizations like Amgen and Biogen Idec. Sobi operates globally, serving hospitals, specialty clinics, and healthcare providers across Europe, North America, the Middle East, Russia, and Asia. With a robust clinical development pipeline and over 150 clinical trials, Sobi is committed to advancing treatments for rare diseases and has reported significant revenue growth, particularly in Europe and the United States.

Basic Information

Industry Pharmaceuticals
Founded 2009
Revenue 2.6B
Headquarters 93a Norra Stationsgatan, Stockholm, Stockholm County, 113 64, Sweden
Parent Organization Investor AB

Contact Details

Key Focus Areas & Initiatives

  • Orphan drugs
  • Hereditary metabolic disorders
  • Haemophilia
  • Biopharmaceuticals
  • Patient access
  • Rare diseases
  • Haematology
  • Hematology
  • Immunology
  • Autoimmune
  • Pharmaceutical manufacturing
  • Medical

Technologies Used

  • Amazon AWS
  • Android
  • Barracuda Networks
  • Bootstrap Framework
  • CloudFlare Hosting
  • Cornerstone On Demand
  • Drupal
  • Google Font API
  • Google Tag Manager
  • Gravity Forms
  • Highcharts JS Library
  • Microsoft Office 365
  • Mobile Friendly
  • OneTrust
  • Outlook
  • Pantheon
  • Ports IT
  • Remote
  • Typekit
  • Vimeo
  • VueJS
  • WordPress.org
  • reCAPTCHA

Affiliated Organizations & Regional Branches

Need more information?

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free
SayData

© 2026 Bitscale. Featherflow Technology Pvt Ltd

LinkedInTwitterInstagramYouTube